SI-BONE, Inc.
Health
Performance
5.7
Risk
Sell
Buy
Curious about the Scores? Learn more.

SI-BONE, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

09.07.2026
Danger zone. Balance sheet’s flashing red across the board.
21.06.2026
Tiny rebound. Signs of life appear after deep struggle.
19.06.2026
Signs of control returning. Still shaky, but not chaos.
16.01.2026
Momentum tanked. Clearly underperforming.
SIBN
SI-BONE, Inc.
17.04
-0.47%
5.7
Sell
Buy
SI-BONE, Inc.

SI-BONE, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does SI-BONE, Inc. do? Business model and key facts

Get the full picture of SI-BONE, Inc.: what it builds, where it operates, and how it makes money.

SI-BONE, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 376

SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.

shop
Company facts
Laura A. Francis
CEO
376
Employees worldwide
shop
Performance
2.22%
Last 12 months
-44.51%
Last 5 years
shop
Growth
$200.93M
Revenue year
$-18,904,000
Net income
shop
Valuation
$770.79M
Market Cap
-44.82
Price/Earnings Ratio

Stocks related to SI-BONE, Inc.

Selected based on industry alignment and relative market positioning.

BVS
Bioventus Inc.
11.88
+2.59%
5.3
Sell
Buy
Bioventus Inc.
INMD
InMode Ltd.
15.36
+0.00%
3.6
Sell
Buy
InMode Ltd.
PRCT
PROCEPT BioRobotics Corporation
18.52
-3.64%
8.3
Sell
Buy
PROCEPT BioRobotics Corporation
TCMD
Tactile Systems Technology, Inc.
28.43
+0.14%
6.7
Sell
Buy
Tactile Systems Technology, Inc.
CERS
Cerus Corporation
3.12
-0.95%
8.2
Sell
Buy
Cerus Corporation

Events and news impacting SI-BONE, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

SI-BONE, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.